SAS Output

19-NOV-2017 6:10

GI ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1505-Panc,Resect, Perioperative Chemo 1 Y 1 mFOLFIRINOX->Surg->mFOLFIRINOX 112 47 9 9 7 2 0 01/06/2016 310 124
        2 Gem/nab-P->Surg->Gem/nab-P   56 15 15 13 2 2      
            103 24 24 20 4 2      
 
  S1513-Panc, Met, FOLFIRI vs mFOLFIRI + ABT-888 1 Y 1 ABT-888 + mFOLFIRI 143 52 51 32 15 4 1 10/27/2016 319 149
        2 FOLFIRI   56 55 37 21 6 1      
            108 106 69 36 10 2      
 
Yes A021302-Gastric, Loc Adv, FDG-PET intervention 0 E Total Registrations   2 0 0 0 0 0 06/17/2016    
            2 0 0 0 0 0      
 
  N1048-Rectal,LocalAdv,ChemoRT+/-FOLFOX 1 E Total Registrations   132 31 15 5 0 0 06/05/2013   161
            132 31 15 5 0 0      
 
  R0848-Panc, Adj, Erlotinib v ChemoRT 1 E Total Registrations   20 0 0 0 0 0 01/24/2011   148
            20 0 0 0 0 0      
 
    2 E Total Registrations   5 0 0 0 0 0 01/24/2011    
            5 0 0 0 0 0      
 
No A021501-Adeno Panc,Borderline Resect,Chemo vs ChemoRT 0 E Total Registrations   11 11 10 6 0 0 05/01/2017   50
            11 11 10 6 0 0      
 
    1 E Total Registrations   10 10 9 6 1 0 05/01/2017    
            10 10 9 6 1 0      
 
  EA2133-Anal, local recur/met, Cis+5FU vs Taxol/Carbo 1 E Total Registrations   1 1 0 0 0 0 03/14/2017   40
            1 1 0 0 0 0      
 
  EA2142-GI NEC, Adv G3, EP vs TMZ + CAP 1 E Total Registrations   4 3 3 1 0 0 07/14/2016 185 71
            4 3 3 1 0 0      
 
  NRGGI002-Rectal, Ph II, Sensitization using TNT 1 E Total Registrations   3 3 1 1 1 1 02/21/2017 320 132
            3 3 1 1 1 1      
 

19-NOV-2017 6:10

GI Open Studies with No Registrations

The REPORT Procedure

Detailed and/or summarized report

Table 1

Study Registration/Phase Open Date
S1613 mCRC, Adv/Met, TP vs CETIRI 1 Screening 09-Oct-17
  2 Randomization 09-Oct-17
  3 Crossover 09-Oct-17